Retail Food Equivalents for Post–Oral Immunotherapy Dosing in the Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen Oral Immunotherapy in Food-Allergic Children and Adults (OUtMATCH) Clinical Trial is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2022). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: UM2AI130836
National Institutes of Health
Grant: 1UL1RR025758
National Institutes of Health
Grant: 1UL1TR001102
National Institutes of Health
Grant: UM1AI130934
National Institutes of Health
Grant: UL1TR003098
National Institutes of Health
Grant: UM1AI130570
National Institutes of Health
Grant: 5UM1AI130780-04
National Jewish Health CoFAR Clinical Research Unit
National Institutes of Health
Grant: 8UL1TR000170
National Institutes of Health
Grant: UM1 AI130936-06
National Institutes of Health
Grant: UM1AI130781
National Institutes of Health
Grant: UL1TR002489
National Institutes of Health
Grant: UL1 TR002535
National Institutes of Health
Grant: UL1TR003107
National Institutes of Health
Grant: UM1AI130838
National Institutes of Health
Grant: 1UL1TR002541-01
The Harvard Clinical and Translational Science Center
Fields of Study
Keywords